Ehrhardt GJ - Search Results

1

Therapeutic radionuclides: production and decay property considerations.

Volkert WA, Goeckeler WF, Ehrhardt GJ, Ketring AR. Volkert WA, et al. Among authors: ehrhardt gj. J Nucl Med. 1991 Jan;32(1):174-85. J Nucl Med. 1991. PMID: 1988628 Free article. Review.

2

Clinical and clinicopathologic effects of samarium-153-EDTMP administered intravenously to normal beagle dogs.

Lattimer JC, Corwin LA Jr, Stapleton J, Volkert WA, Ehrhardt GJ, Ketring AR, Hewett JE, Simon J, Goeckeler WF. Lattimer JC, et al. Among authors: ehrhardt gj. J Nucl Med. 1990 May;31(5):586-93. J Nucl Med. 1990. PMID: 2341893 Free article.

3

Clinical and clinicopathologic response of canine bone tumor patients to treatment with samarium-153-EDTMP.

Lattimer JC, Corwin LA Jr, Stapleton J, Volkert WA, Ehrhardt GJ, Ketring AR, Anderson SK, Simon J, Goeckeler WF. Lattimer JC, et al. Among authors: ehrhardt gj. J Nucl Med. 1990 Aug;31(8):1316-25. J Nucl Med. 1990. PMID: 2384798 Free article.

4

A new Cd-115 leads to In-115m radionuclide generator.

Ehrhardt GJ, Volkert W, Goeckeler WF, Kapsch DN. Ehrhardt GJ, et al. J Nucl Med. 1983 Apr;24(4):349-52. J Nucl Med. 1983. PMID: 6834137 Free article.

5

Reactor-produced radionuclides at the University of Missouri Research Reactor.

Ehrhardt GJ, Ketring AR, Ayers LM. Ehrhardt GJ, et al. Appl Radiat Isot. 1998 Apr;49(4):295-7. doi: 10.1016/s0969-8043(97)00038-9. Appl Radiat Isot. 1998. PMID: 9519439 Review.

6

Labeling of antibodies with 64Cu using a conjugate containing a macrocyclic amine chelating agent.

Franz J, Freeman GM, Barefield EK, Volkert WA, Ehrhardt GJ, Holmes RA. Franz J, et al. Among authors: ehrhardt gj. Int J Rad Appl Instrum B. 1987;14(5):479-84. doi: 10.1016/0883-2897(87)90113-9. Int J Rad Appl Instrum B. 1987. PMID: 3667312

7

Preparation of cyclotron-produced 186Re and comparison with reactor-produced 186Re and generator-produced 188Re for the labeling of bombesin.

Moustapha ME, Ehrhardt GJ, Smith CJ, Szajek LP, Eckelman WC, Jurisson SS. Moustapha ME, et al. Among authors: ehrhardt gj. Nucl Med Biol. 2006 Jan;33(1):81-9. doi: 10.1016/j.nucmedbio.2005.09.006. Nucl Med Biol. 2006. PMID: 16459262

8

Therapeutic use of 90Y microspheres.

Ehrhardt GJ, Day DE. Ehrhardt GJ, et al. Int J Rad Appl Instrum B. 1987;14(3):233-42. doi: 10.1016/0883-2897(87)90047-x. Int J Rad Appl Instrum B. 1987. PMID: 3667306

9

Rhenium-188(Sn)HEDP for treatment of osseous metastases.

Maxon HR 3rd, Schroder LE, Washburn LC, Thomas SR, Samaratunga RC, Biniakiewicz D, Moulton JS, Cummings D, Ehrhardt GJ, Morris V. Maxon HR 3rd, et al. Among authors: ehrhardt gj. J Nucl Med. 1998 Apr;39(4):659-63. J Nucl Med. 1998. PMID: 9544677 Free article.

10

Technetium- and rhenium-labeled progestins: synthesis, receptor binding and in vivo distribution of an 11 beta-substituted progestin labeled with technetium-99 and rhenium-186.

DiZio JP, Anderson CJ, Davison A, Ehrhardt GJ, Carlson KE, Welch MJ, Katzenellenbogen JA. DiZio JP, et al. Among authors: ehrhardt gj. J Nucl Med. 1992 Apr;33(4):558-69. J Nucl Med. 1992. PMID: 1552341 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

18 results

Search Page

Filters